205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-51.02%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
-52.73%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
-46.54%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
9.15%
Margin expansion exceeding 1.5x MCHP's 5.18%. David Dodd would verify competitive advantages.
-55.80%
Both companies reducing R&D. Martin Whitman would check industry innovation trends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.72%
Operating expenses reduction while MCHP shows 0.00% growth. Joel Greenblatt would examine advantage.
-46.87%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
120.00%
D&A growth above 1.5x MCHP's 20.51%. Michael Burry would check for excessive investment.
-7.91%
EBITDA decline while MCHP shows 0.73% growth. Joel Greenblatt would examine position.
-120.30%
EBITDA margin decline while MCHP shows 9.12% growth. Joel Greenblatt would examine position.
-55.20%
Both companies show declining income. Martin Whitman would check industry conditions.
-216.85%
Operating margin decline while MCHP shows 0.54% growth. Joel Greenblatt would examine position.
-250.00%
Other expenses reduction while MCHP shows 100.00% growth. Joel Greenblatt would examine advantage.
-66.92%
Pre-tax income decline while MCHP shows 123.46% growth. Joel Greenblatt would examine position.
-240.77%
Pre-tax margin decline while MCHP shows 142.05% growth. Joel Greenblatt would examine position.
-666.67%
Tax expense reduction while MCHP shows 86.96% growth. Joel Greenblatt would examine advantage.
80.95%
Net income growth 50-75% of MCHP's 137.93%. Martin Whitman would scrutinize operations.
61.11%
Net margin growth below 50% of MCHP's 157.73%. Michael Burry would check for structural issues.
81.13%
EPS growth 50-75% of MCHP's 137.72%. Martin Whitman would scrutinize operations.
81.13%
Diluted EPS growth 50-75% of MCHP's 137.72%. Martin Whitman would scrutinize operations.
0.19%
Share count increase while MCHP reduces shares. John Neff would investigate differences.
0.19%
Diluted share increase while MCHP reduces shares. John Neff would investigate differences.